Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2021

View Archived Issues

Omega selects OTX-2002 as development candidate for MYC-driven HCC

Chi3l1/YKL-40 as therapeutic target to slow the progression of AD

Positive interim data from controlled study of KB-109 in outpatients with COVID-19

FDA clears IND application for phase I/IIa study of VOR-33 in AML

First patient enrolled in phase IIb VISTAS study of volixibat in adults with PSC

CanSino Biologics patents glycoconjugates as vaccines for pneumococcal infections

Array BioPharma discloses BRAF mutant inhibitors

IL-37 and IL-1R8 deficiencies contribute to the pathogenesis of necrotizing enterocolitis

Binding of NAD+ to the ARM domain in SARM1 self-inhibits SARM1 to avoid axonal degeneration

Investigators present new antibodies for malaria

Japanese researchers propose Lister hooded rats as a new model of ADHD

Chinese approval of Rykindo for schizophrenia and psychotic states

CJ-2360 achieves complete tumor regression in ALK-positive xenografts

Bimagrumab improves traits in patients with type 2 diabetes and obesity

Glutamine aids and abets senescent cell survival

New classification scheme for glioblastomas

Mis-spliced RNAs in tumor cells trigger antiviral response

PW-0787, a novel potent and brain-penetrant GPR52 agonist for neuropsychiatric disorders

FDA approves Xalkori for ALK-positive ALCL in children and young adults

PK/PD effect studies evaluating differences in clinical efficacy of LEO-29102 and LEO-39652

Phase I/II results for COVID-19 vaccine Ad26.COV2.S support its further development

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...